Treace Medical Concepts Inc.

TMCI | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.64

+$0.16 (+3.57%)

Sep 22, 2026, 2:33 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.57%

(1D)

Rating

Updated: Aug 19, 2026

32.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $301.01M

1D Range

4.45 4.64

52W Range

1.17 7.10

Valuation (TTM)

PE -4.82

PB 4.29

EV/EBITDA -5.40

Valuation (NTM)

Forward PE N/A

Forward PEG 0.55

Price Target $8.60

Cash Flow

FCF Yield -8.6%

SBC Adj. FCF Yield -19.0%

SBC Impact -120.0%

Margins

Gross Margin 79.5%

Operating Margin -26.2%

FCF Margin -12.2%

Growth (CAGR)

Revenue 3Y | 5Y 7.1% | 21.4%

Dil EPS 3Y | 5Y 4.9% | -5.7%

FCF 3Y | 5Y 25.8% | 13.8%

Returns

ROA -32.9%

ROE -74.1%

ROIC -37.5%

Financial Health

Net Cash

$32.53M

Current Ratio 2.90

Interest Coverage -9.23

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct ...

Sector Healthcare

Industry Medical - Devices

Employees 450

IPO Date Apr 22, 2021

Website www.treace.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$6.50

Upside

+40.09%

Buy (1)

Hold (4)

Sell (1)

Analyst Details ➞